Department of Community Health
8 N. Main St.
Suite 404
Attleboro, MA
USA 02703
degilman@neveragainconsulting.com
4426.0 From development to withdrawal of Raptiva: A case study examining conflicts of interest in pharma-FDA relationships, inadequate safety studies, and circumvention of the physician intermediary